[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Generic_Tina Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1511682976639119365.png) Tina Banerjee [@Generic_Tina](/creator/twitter/Generic_Tina) on x XX followers
Created: 2025-06-01 00:35:24 UTC

Eisai's Dayvigo approved in China. Daiichi Sankyo withdrew BLA in US. Samsung Bio secures CMO contracts. SK Bioscience expands vaccine manufacturing facility. CSPC is in outlicensing talks.

![](https://pbs.twimg.com/card_img/1928973630920339457/knBOENB0?format=jpg&name=800x419)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1928973619079819639/c:line.svg)

**Related Topics**
[$302440ks](/topic/$302440ks)
[samsung](/topic/samsung)
[$6417t](/topic/$6417t)
[$4568t](/topic/$4568t)
[$8750t](/topic/$8750t)
[china](/topic/china)
[approved](/topic/approved)

[Post Link](https://x.com/Generic_Tina/status/1928973619079819639)